ITT (ITT) Q1 2026 Earnings Call Transcript

ITT delivered a strong Q1 with revenue up 33% to $1.2 billion, orders up 26%, adjusted EPS up 25% to $1.98, and operating margin expanding 130 bps to 21.1%. The newly closed SPX FLOW acquisition added 17 points of growth, was immediately accretive, and management identified $80 million of cost synergies, while 2026 guidance calls for 37% revenue growth, 5% organic growth, and EPS of $7.70-$8.00. The company also repurchased $100 million of stock and guided to roughly $560 million of free cash flow in 2026.

Analysis

ITT’s print is less about a one-quarter beat and more about a step-change in earnings power from the SPX FLOW integration. The market should focus on the quality of the accretion: management is already showing revenue cross-sell, not just cost takeout, which means the acquisition can de-risk the leverage story faster than typical industrial roll-ups. The key second-order effect is that the new Flow platform gives ITT a broader distribution and manufacturing footprint, so future synergies can come from SKU rationalization, plant loading, and channel-sharing rather than only G&A cuts.

The bigger hidden upside is operating leverage in legacy businesses while the new asset normalizes. CCT still looks like the cleanest margin expansion engine because pricing power and aerospace demand are reinforcing each other; MT is the least exciting segment, but even there the company is taking share in a down auto market, which suggests the base algorithm is stronger than consensus models likely assume. If management sustains even a mid-single-digit organic growth rate while improving mix and productivity, the year-end EPS setup can outgrow the current guide, especially once the extra selling-day tailwind rolls off and gets replaced by true underlying demand.

The main risk is not demand, it’s execution friction: integration complexity, a higher tax rate, and rising interest expense can obscure the underlying operating momentum for several quarters. The market may underappreciate how much of the Q1 margin benefit was front-loaded by timing and acquisition accounting, so headline EPS could look flatter in Q2-Q4 even if the business is improving underneath. That creates an opportunity for volatility around each print, especially if investors expect linear accretion from SPX FLOW; the setup is more stair-step than smooth.

The contrarian take is that the stock may still be cheap relative to the quality of the industrial compounding model. If the market treats this as a “good industrial with an acquisition” rather than a structurally better franchise, rerating could lag fundamentals for months, which is attractive for patient capital. The asymmetric view is that execution at SPX FLOW plus continued share gains in defense, connectors, and automotive friction can push ITT from a steady compounder into a self-funded growth story with recurring buyback capacity.

Key Decisions for Investors

• Go long ITT on any post-earnings consolidation over the next 2-6 weeks; upside comes from multiple expansion if investors re-rate the SPX FLOW accretion, while downside is cushioned by buybacks and visible backlog growth.
• Pair trade: long ITT / short a lower-quality industrial compounder with weaker pricing power and no M&A catalyst; thesis is that ITT’s organic growth plus acquisition synergies should drive relative outperformance over the next 2-3 quarters.
• Buy ITT call spreads 3-6 months out into weakness, targeting a grind higher as synergy realization and revenue cross-sell become clearer; the trade benefits from limited premium outlay versus potential guide-up risk.
• Fade near-term disappointment risk by avoiding chasing after strong sessions: Q2-Q3 EPS may look less explosive than Q1, so use volatility to add rather than paying up on headline momentum.
• Watch for a catalyst break above consensus EPS if margin expansion continues; if that happens, consider adding to the long and trimming only if integration costs or tax rate comments start to pressure the narrative.